8190.Ng
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
Business. The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
The company operates in the Food & Drug Retailing sector, generating revenue primarily through the sale of food and drug products to consumers.
The company's capital structure shows a debt-to-equity ratio of 0.61, indicating a moderate reliance on debt financing. However, the current ratio of 0.79 suggests potential liquidity constraints, as current liabilities exceed current assets. The company's liquidity position is further complicated by a negative free cash flow of -152 million JPY and a capital expenditure of -1.621 billion JPY, which may signal ongoing investment in operations.
Profitability metrics reveal a return on equity of 0.56% and a return on assets of 0.24%, both of which are below the typical thresholds for healthy performance in the retail sector. The operating income is negative at -296 million JPY, which is a significant concern given the company's revenue of 83.24 billion JPY. This suggests that the company is struggling to convert its sales into profit, which could be a red flag for investors.
The company's revenue is concentrated in a single business segment, as disclosed in the financial snapshot, with no specific geographic breakdown provided. This lack of diversification could pose a risk if the company's primary market experiences economic downturns or regulatory changes. The absence of detailed segment and geographic data limits the ability to assess the company's exposure to different markets.
The company's growth trajectory is uncertain, as the operating income is negative and the free cash flow is also negative. The capital expenditure of -1.621 billion JPY indicates ongoing investment, but without a clear path to profitability, the long-term growth prospects are unclear. The company's net income of 102 million JPY is modest and does not provide a strong foundation for future expansion.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt is a concern, as it suggests the company may struggle to meet short-term obligations. The dilution risk is low, which is a positive sign for shareholders, but the company's financial health remains a concern due to the negative operating income and free cash flow.
Recent events, as reflected in the financial data, show a last actual EPS of 5.36 JPY and a last actual revenue of 83.24 billion JPY. These figures indicate that the company is meeting analyst expectations in terms of revenue but is underperforming in terms of profitability. The negative operating income and free cash flow suggest that the company is facing operational challenges that need to be addressed.
- The company has a moderate debt-to-equity ratio but faces liquidity constraints as indicated by a current ratio below 1.
- Profitability is weak, with a negative operating income and low return on equity and assets.
- The company's revenue is concentrated in a single segment, increasing exposure to market-specific risks.
- Growth is uncertain due to negative free cash flow and capital expenditure, with no clear path to profitability.
- Liquidity risk is medium, and dilution risk is low, but the company's financial health remains a concern.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- 8190.NG Market data — financials · 2026-05-27
- Yamanaka Co Ltd Market data — analyst estimates · 2026-05-27